Ligand Pharmaceuticals | LGND - Текущие активы





Текущие активы Изменить Дата
Agenus USD 133.44M 514K 2025-12
Amgen USD 31.48B 2.42B 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.17B 223.75M 2025-12
Baxter International USD 6.85B 25M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 720.68M 48.56M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Merck USD 35.02B 8.5B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 488.38M 39.15M 2025-12